OBJECTIVE: The cytosolic form of Cu/Zn-containing superoxide dismutase (SOD1) has peroxidase activity, with H2O2 used as a substrate to oxidize other molecules. We examined peroxidase properties of the extracellular form of SOD (SOD3), a major isoform of SOD in the vessel wall, by using recombinant SOD3 and an in vivo model of atherosclerosis. METHODS AND RESULTS: In the presence of HCO3-, SOD3 reacted with H2O2 to produce a hydroxyl radical adduct of the spin trap 5-diethoxyphosphoryl-5methyl-1-pyrroline N-oxide (DEMPO). SOD1 and SOD3 were inactivated by H2O2 in a dose- and time-dependent fashion, and this was prevented by physiological levels of uric acid. To examine the in vivo role of uric acid on SOD1 and SOD3, control and apolipoprotein E-deficient (ApoE(-/-)) mice were treated with oxonic acid, which inhibits urate metabolism. This treatment increased plasma levels of uric acid in control and ApoE(-/-) mice by approximately 3-fold. Although increasing uric acid levels did not alter aortic SOD1 and SOD3 protein expression, aortic SOD1 and SOD3 activities were increased by 2- to 3-fold in aortas from ApoE(-/-) mice but not in aortas from control mice. CONCLUSIONS: These studies show that SOD1 and SOD3 are partially inactivated in atherosclerotic vessels of ApoE(-/-) mice and that levels of uric acid commonly encountered in vivo may regulate vascular redox state by preserving the activity of these enzymes.
OBJECTIVE: The cytosolic form of Cu/Zn-containing superoxide dismutase (SOD1) has peroxidase activity, with H2O2 used as a substrate to oxidize other molecules. We examined peroxidase properties of the extracellular form of SOD (SOD3), a major isoform of SOD in the vessel wall, by using recombinant SOD3 and an in vivo model of atherosclerosis. METHODS AND RESULTS: In the presence of HCO3-, SOD3 reacted with H2O2 to produce a hydroxyl radical adduct of the spin trap 5-diethoxyphosphoryl-5methyl-1-pyrroline N-oxide (DEMPO). SOD1 and SOD3 were inactivated by H2O2 in a dose- and time-dependent fashion, and this was prevented by physiological levels of uric acid. To examine the in vivo role of uric acid on SOD1 and SOD3, control and apolipoprotein E-deficient (ApoE(-/-)) mice were treated with oxonic acid, which inhibits urate metabolism. This treatment increased plasma levels of uric acid in control and ApoE(-/-) mice by approximately 3-fold. Although increasing uric acid levels did not alter aortic SOD1 and SOD3 protein expression, aortic SOD1 and SOD3 activities were increased by 2- to 3-fold in aortas from ApoE(-/-) mice but not in aortas from control mice. CONCLUSIONS: These studies show that SOD1 and SOD3 are partially inactivated in atherosclerotic vessels of ApoE(-/-) mice and that levels of uric acid commonly encountered in vivo may regulate vascular redox state by preserving the activity of these enzymes.
Authors: Christine Gersch; Sergiu P Palii; Witcha Imaram; Kyung Mee Kim; S Ananth Karumanchi; Alexander Angerhofer; Richard J Johnson; George N Henderson Journal: Nucleosides Nucleotides Nucleic Acids Date: 2009-02 Impact factor: 1.381
Authors: Candice D Fike; Anna Dikalova; James C Slaughter; M R Kaplowitz; Y Zhang; Judy L Aschner Journal: Antioxid Redox Signal Date: 2013-01-29 Impact factor: 8.401
Authors: Stephen Wedgwood; Satyan Lakshminrusimha; Lyubov Czech; Paul T Schumacker; Robin H Steinhorn Journal: Antioxid Redox Signal Date: 2013-02-15 Impact factor: 8.401
Authors: Jin Oshikawa; Norifumi Urao; Ha Won Kim; Nihal Kaplan; Masooma Razvi; Ronald McKinney; Leslie B Poole; Tohru Fukai; Masuko Ushio-Fukai Journal: PLoS One Date: 2010-04-21 Impact factor: 3.240
Authors: Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-07-03 Impact factor: 5.464
Authors: Maria Carolina Gongora; Heinrich E Lob; Ulf Landmesser; Tomasz J Guzik; W David Martin; Kiyoski Ozumi; Susan M Wall; David Scott Wilson; Niren Murthy; Michael Gravanis; Tohru Fukai; David G Harrison Journal: Am J Pathol Date: 2008-09-11 Impact factor: 4.307